Two-thirds of Americans approve of editing human DNA to treat disease
By Alessandra Potenza,
The Verge
| 08. 30. 2017
About two-thirds of Americans support the use of gene editing to treat diseases, according to a new survey. But opinions vary a lot based on people’s religious beliefs and how much they know about gene editing in general.
The research, published earlier this month in Science, shows that across the board, people want to be involved in a public discussion about editing the human genome. And that conversation with scientists and public officials needs to happen now, as the technology is still developing, says study co-author Dietram Scheufele, a science communication scholar at the University of Wisconsin-Madison. The results are based on a survey of 1,600 US adults conducted in December 2016 and January 2017.
The goal of the survey was to probe public opinion on a revolutionary piece of technology that’s advancing fast, Scheufele tells The Verge. The advent of powerful gene editing tools like CRISPR is making editing human DNA incredibly easy and precise. The technology holds the potential to rid humanity of diseaseslike sickle cell anemia. Earlier this month, researchers in the US...
Related Articles
By Virginia Heffernan, The New Republic | 05.29.2026
Here and there, it’s been a good month for humanity—or “magnificas humanitas,” as Pope Leo XIV calls us poor featherless bipeds.
On May 25, the pope published his encyclical letter “on safeguarding the human person in the time of artificial...
By Sonya Borrero, Christine Dehlendorf, and Rachel Logan, Stat | 05.01.2026
America is worried about fertility rates — again.
Coverage of the country’s declining birth rate reflects widespread unease: Families are struggling, young adults are delaying or forgoing parenthood, and the future labor force feels uncertain. These concerns are rooted in...
By Emile P. Torres, Truthdig | 04.27.2026
The CEO of OpenAI, Sam Altman, is on a messianic mission to bring about the singularity, the moment at which artificial intelligence begins to self-improve. If AI is smart enough to build the next generation of even smarter AI...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...